Skip to ContentSkip to Navigation
How to find us A.E.S. (Auke) de Zwart, BSc


Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients

Mycophenolic Acid Has Intrinsic Antiviral Properties and Potentiates the Antiviral Effect of Ribavirin on Parainfluenza Virus

Repurposed Oral Ribavirin for Respiratory Virus Infections Requires Pharmacokinetic-pharmacodynamic Dose Optimization

Respiratory syncytial virus infection morbidity in the elderly; time for repurposing of ribavirin?

Ten Years of Ribavirin Treatment for Pneumovirus and Paramyxovirus Infections in Lung Transplant Recipients

Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens

Read more